Submitted by Lorenzo.Piemonte on Tue, 05/31/2016 - 11:57
Insulin was discovered in 1921, first used by an individual with type 1 diabetes in 1922 and then became widely available in the “Western world”. Challenges of access to insulin have been documented and these relate mainly to issues of availability, price and affordability, particularly in low- and middle-income countries.
Submitted by aabolina on Wed, 02/26/2014 - 12:00
Submitted by aabolina on Wed, 02/26/2014 - 11:36
More and more frequently insulin is being recommended as an ‘add-on’ to oral hypoglycaemic therapy for the achievement of blood glucose targets in people with established type 2 diabetes. Indeed, there are now trials of insulin therapy in type 2 diabetes from diagnosis. Concerns have been raised in the recent medical literature that long-term insulin therapy in type 2 diabetes increases the risk of cardiovascular disease and some cancers. We have asked specialists in the fields of clinical diabetes and pharmacoepidemiology to comment on the question:
Submitted by aabolina on Mon, 11/25/2013 - 13:50
Submitted by aabolina on Thu, 08/22/2013 - 11:51
Submitted by aabolina on Thu, 08/22/2013 - 10:08
Graham Ogle, Angie Middlehurst and Robyn Short-Hobbs
Submitted by aabolina on Thu, 08/22/2013 - 09:37
Submitted by aabolina on Wed, 08/21/2013 - 15:24
Joyce P. Yi-Frazier and colleagues for the SEARCH for Diabetes in Youth Study Group
Submitted by aabolina on Wed, 08/21/2013 - 13:43
Taking type 1 diabetes to school is the subject of the second instalment for our Voices of type 1 diabetes series which features first person accounts of people living with either type 1 or type 2 diabetes and their perspectives on managing the conditions in our world today.
Submitted by aabolina on Thu, 05/23/2013 - 16:09
Targeting today’s most contemporary issues, the Basic and Clinical Science Stream may provide this year’s Congress with the biggest buzz, especially in areas of obesity, diabetes complications and new treatment strategies. A range of provocative topics including debates about driving type 2 diabetes prevention and bariatric surgery will be presented. Noteworthy speakers will discuss new treatment options for both types of diabetes and present the latest results of clinical trials. Mark Cooper and Sophia Zoungas talk about the exciting programme this year.